Manufacturer
10 recalls in our database name Hospira Inc., A Pfizer Company as the manufacturing or recalling firm.
Of the 10 recalls from Hospira Inc., A Pfizer Company we have scored against our rubric, 1 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 5 (50%) are Severe.
Which agencies issued them
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Hospira Inc. is recalling Labetalol Hydrochloride Injection vials because of cracked glass at the rim, which is covered by the stopper and crimp seal.
Hospira is recalling 701 vials of Argatroban Injection because a denitroquinoline-related impurity exceeded specifications during testing.
Hospira is recalling specific lots of Levophed (norepinephrine bitartrate) injection after a foreign stopper was observed during packaging.
Hospira is recalling 30,880 vials of Vancomycin Hydrochloride for Injection because a hair was found inside a vial and contacted the drug.
Hospira is recalling 62,847 Plum 360 Infusion Pumps with software version 15.02 due to a defect that causes therapy to stop and incorrect alarms to display.
Hospira is recalling 578,784 bags of Metronidazole Injection due to a customer report of a leaking bag, which compromises sterility assurance.
Hospira Inc. is recalling 143,250 vials of Bupivacaine Hydrochloride Injection due to a confirmed report of particulate matter in a single vial.
Hospira is recalling 15 vials of Marcaine 0.25% injection because a glass defect allowed water to enter, compromising sterility and reducing drug potency.
Hospira is recalling 4,768 vials of Marcaine 0.5% injection because a glass defect allowed water ingress, compromising sterility and reducing drug potency.
Hospira is recalling MedNet 6.1 software used with SapphirePlus infusion pumps because it may calculate incorrect bolus amounts for drugs in Million Units.